KR830005149A - 4'-(9-아크리디닐아미노)메탄설폰-m-아니시다이드 염의 제법 - Google Patents

4'-(9-아크리디닐아미노)메탄설폰-m-아니시다이드 염의 제법

Info

Publication number
KR830005149A
KR830005149A KR1019810000773A KR810000773A KR830005149A KR 830005149 A KR830005149 A KR 830005149A KR 1019810000773 A KR1019810000773 A KR 1019810000773A KR 810000773 A KR810000773 A KR 810000773A KR 830005149 A KR830005149 A KR 830005149A
Authority
KR
South Korea
Prior art keywords
preparation
acridinylamino
anisidide
methanesulfone
salt
Prior art date
Application number
KR1019810000773A
Other languages
English (en)
Other versions
KR840001561B1 (ko
Inventor
알. 휘셔 제임스
피. 쿨리어 챨스
Original Assignee
토마스. 몰티터노
워너 램버트 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 토마스. 몰티터노, 워너 램버트 캄파니 filed Critical 토마스. 몰티터노
Publication of KR830005149A publication Critical patent/KR830005149A/ko
Application granted granted Critical
Publication of KR840001561B1 publication Critical patent/KR840001561B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02—Acyclic radicals
    • C07H7/033—Uronic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C07D219/10—Nitrogen atoms attached in position 9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02—Acyclic radicals
    • C07H7/027—Keto-aldonic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

내용 없음

Description

4'-(9-아크리디닐아미노)메탄설폰-m-아니시다이드 염의 제법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 본문에 상술한 바와 같이, 다음 일반식(2)의 화합물을 산 X와 반응시키는 것으로 구성된, 다음 일반식(1)화합물의 제법.
    식중, X는 총 3-6개의 탄탄소원자, 2-5개의 하이드록시기를 갖는산 및 탄소원자수가 총 3-4개이고 산기가 OPO3H2인 조건하에, -CO2H기 또는 -OPO3H2기일수 있다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019810000773A 1980-03-11 1981-03-10 4'-(9-아크리디닐아미노) 메탄설폰-m-아니시 다이드염의 제법 KR840001561B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12950380A 1980-03-11 1980-03-11
US129503 1980-03-11

Publications (2)

Publication Number Publication Date
KR830005149A true KR830005149A (ko) 1983-08-03
KR840001561B1 KR840001561B1 (ko) 1984-10-05

Family

ID=22440294

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810000773A KR840001561B1 (ko) 1980-03-11 1981-03-10 4'-(9-아크리디닐아미노) 메탄설폰-m-아니시 다이드염의 제법

Country Status (16)

Country Link
EP (1) EP0035862B1 (ko)
JP (1) JPS56142265A (ko)
KR (1) KR840001561B1 (ko)
AR (1) AR225346A1 (ko)
AT (1) ATE7911T1 (ko)
AU (1) AU535610B2 (ko)
CA (1) CA1253160A (ko)
DE (1) DE3164054D1 (ko)
DK (1) DK161072C (ko)
ES (1) ES8202332A1 (ko)
HU (1) HU183357B (ko)
IE (1) IE50967B1 (ko)
MX (1) MX6764E (ko)
NZ (1) NZ196461A (ko)
SU (1) SU1192619A3 (ko)
ZA (1) ZA811304B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322424A (en) * 1980-01-24 1982-03-30 Bristol-Myers Company Crystalline glucoconate salt of m-AMSA and compositions containing same
ES512969A0 (es) * 1981-06-11 1983-02-16 Warner Lambert Co "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".
US4575509A (en) * 1983-01-31 1986-03-11 Bristol-Myers Company Water-soluble formulations of m-AMSA with pyroglutamic acid
DE3844518A1 (de) * 1988-03-23 1989-10-05 Karl Heinz Dr Med Thiel Verwendung von aminochinolinen und aminopyridinen zur iontophoretischen behandlung maligner tumore
EP3707127A4 (en) * 2017-11-09 2021-12-01 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. COMPOUNDS FOR INHIBITION OF LY6K AND METHOD OF USING THEREOF

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1674923A (en) * 1924-04-12 1928-06-26 Schnorf Carl Process for the production of carbohydrate-acridine compounds and solutions thereof
ZA805652B (en) * 1979-09-14 1981-09-30 New Zealand Dev Finance Compounds having antitumour properties
JPS5687566A (en) * 1979-11-30 1981-07-16 Bristol Myers Co Anticancerous composition
ZA81420B (en) * 1980-01-24 1982-02-24 Bristol Myers Co Antitumor compositions

Also Published As

Publication number Publication date
IE810396L (en) 1981-09-11
DK161072C (da) 1991-11-11
MX6764E (es) 1986-06-30
ZA811304B (en) 1982-06-30
DK161072B (da) 1991-05-27
AU535610B2 (en) 1984-03-29
DE3164054D1 (en) 1984-07-19
SU1192619A3 (ru) 1985-11-15
JPH0343269B2 (ko) 1991-07-01
DK109181A (da) 1981-09-12
EP0035862A3 (en) 1981-11-18
NZ196461A (en) 1982-12-21
EP0035862B1 (en) 1984-06-13
ATE7911T1 (de) 1984-06-15
AR225346A1 (es) 1982-03-15
KR840001561B1 (ko) 1984-10-05
ES500228A0 (es) 1982-01-16
CA1253160A (en) 1989-04-25
EP0035862A2 (en) 1981-09-16
AU6819281A (en) 1981-09-17
IE50967B1 (en) 1986-08-20
JPS56142265A (en) 1981-11-06
ES8202332A1 (es) 1982-01-16
HU183357B (en) 1984-04-28

Similar Documents

Publication Publication Date Title
KR860001110A (ko) 항균제 ⅱ의 제법
KR850007208A (ko) 약산성욕 염조성물
KR860008770A (ko) 화 장 품
KR830001214A (ko) 1,2,4,5-테트라-알킬-4-아릴피페리딘
KR890009962A (ko) 매뉴마이신 유도체, 이의 제조방법 및 용도
KR830005149A (ko) 4'-(9-아크리디닐아미노)메탄설폰-m-아니시다이드 염의 제법
KR900002125A (ko) 내식막 조성물
KR830005325A (ko) 수용성 화학 발광 시스템
KR840008329A (ko) 2-에틸-4-메틸이미다졸의 결정화 방지방법
KR890004994A (ko) 신규 백금 착화합물
KR840004431A (ko) 히단토인 치료제
KR910009720A (ko) 알콕시메틸리덴 에피포도필로톡신 배당체
KR860002421A (ko) 2가(價) 3가 철염(鐵鹽)배합물 및 그 제조법
KR840001144A (ko) 5(6)-페닐설포닐옥시-벤즈이미다졸 유도체의 제조방법
KR880001213A (ko) 수중부착 생물방제제
KR830009135A (ko) 4-피라졸릴 아린산 에스테르 유도체 및 그 제조방법
KR890014122A (ko) 한천을 이용한 암진단용 밀론시약 제형
SU724561A1 (ru) Антистатическа добавка к мазуту
KR890006597A (ko) 5-알콕시-2-(4-알콕시페닐)피리미딘
KR870003089A (ko) 1-카바페넴 및 1-카바세펨 제조중간체의 제조방법
KR830003493A (ko) 안사마이신에 산소함유기능기를 도입시키는 방법
KR830010076A (ko) 옥타하이드로 피라졸로(3,4-g)퀴놀린
Proctor The effect of teachers' theoretical orientations on the writing produced by grade one students
KR830006215A (ko) 4-저급알킬-3-페녹시피리딘-1-옥사이드의 제조방법
KR880011095A (ko) 신규한 포스피노 피롤리딘 화합물